Abstract
The therapeutic efficacy of intra-arterial cis-Diamminedichloroplatinum-II on the primary tumor was assessed in relationship to survival. Patients with a combined complete and partial response (over 60% necrosis) had a 64% metastases-free survival, and those with no response (under 60% necrosis) a 34% survival.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Jaffe N, Knapp J, Chuang VP, et al.: Osteosarcoma: intra-arterial treatment of the primary tumor with cis-Diamminedichloroplatinum-II (CDP): angiographic, pathologic and pharmacologic studies. Cancer 51:402–407, 1983.
Jaffe N, Robertson R, Ayala A, et al.: Comparison of intra-arterial cis-Diamminedichloroplatinum-II with high dose methotrexate and citrovorum factor rescue in the treatment of primary osteosarcoma. J Clin Oncol 3:1101–1104, 1985.
Jaffe N, Murray JA, Ayala A, et al.: Osteosarcoma limb salvage with preoperative chemotherapy. In The Design and Application of Tumor Prostheses for Bone and Joint Reconstruction. Chao EY-S, Iving JC (Eds.), New York, Thieme-Stratton Inc, New York Georg Thieme, Verlag Stuttgart, pp.69–77, 1983.
Jaffe N, Spears R, Eftekhari F, et al.: Pathologic fracture in osteosarcoma: impact of chemotherapy on primary tumor and survival. Cancer 59:0027–0035, 1987.
Kaplan EL, Meier R: Nonparametric estimation from incomplete observation. J Am Stat Assoc 53:457–481, 1958.
Gehan EA: A generalized Wilcoxon test for comparing arbitrarily singly — censored samples. Biometrika 52: 203–223, 1965.
Sutow WW, Gehan EA, Vietti TJ, et al.: Multi-drug chemotherapy in primary treatment of osteosarcoma. J Bone Joint Surg 58A:629–633, 1976.
Weiner MA, Harris MB, Lewis M, et al.: Neoadjuvant high dose methotrexate, cisplatin and doxorubicin for the management of patients with non-metastatic osteosarcoma. Cancer Treat Rep 70:1431–1432, 1986.
Goorin AM, Perez-Atayde A, Gebhardt M, et al.: Weekly high dose methotrexate and doxorubicin for osteosarcoma: The Dana Farber Cancer Center Institute/The Children’s Hospital Study III. J Clin Oncol 5:1178–1184, 1984.
Link MP, Goorin AM, Miser AW, et al.: The effect of adjuvant chemotherapy on relapse free survival in patients with osteosarcoma of the extremity. N Engl J Med 314:1600–1606, 1986.
Rosen G, Caparros B, Nirenberg A, et al.: Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49:1221–1230, 1982.
Jaffe N: Chemotherapy in Osteosarcoma: Advances and controversies. In Experimental and Clinical Progress in Cancer Chemotherapy. Muggia FM (Ed.), Boston, Martinus Nijhoff, pp.223–233, 1985.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
Jaffe, N. et al. (1988). Intra-Arterial Cis-Diamminedichloroplatinum-II in Pediatric Osteosarcoma: Relationship of Effect on Primary Tumor to Survival. In: Ryan, J.R., Baker, L.O. (eds) Recent Concepts in Sarcoma Treatment. Developments in Oncology, vol 55. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2691-2_43
Download citation
DOI: https://doi.org/10.1007/978-94-009-2691-2_43
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7714-9
Online ISBN: 978-94-009-2691-2
eBook Packages: Springer Book Archive